These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9766465)

  • 21. Mechanism of increased kanamycin-resistance generated by protoplast regeneration of Streptomyces griseus. I. Cloning of a gene segment directing a high level of an aminoglycoside 3-N-acetyltransferase activity.
    Hotta K; Ishikawa J; Ichihara M; Naganawa H; Mizuno S
    J Antibiot (Tokyo); 1988 Jan; 41(1):94-103. PubMed ID: 3126171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycin.
    Inouye Y; Hashimoto M; Sugiyama M; Takesue Y; Santo T; Yokoyama T
    Hiroshima J Med Sci; 1994 Sep; 43(3):87-92. PubMed ID: 7534753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kanamycin and its derivative, arbekacin: significance and impact.
    Hotta K; Kondo S
    J Antibiot (Tokyo); 2018 Mar; 71(4):417-424. PubMed ID: 29402999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus.
    Inoue M; Nonoyama M; Okamoto R; Ida T
    Drugs Exp Clin Res; 1994; 20(6):233-9. PubMed ID: 7758395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Necessity and usefulness of detection by PCR of mecA and aac(6')/aph(2") genes for identification of arbekacin-resistant MRSA].
    Hotta K; Ishikawa J; Ishii R; Saitoh F; Kira K; Arakawa Y; Ike Y
    Jpn J Antibiot; 1999 Aug; 52(8):525-32. PubMed ID: 10587877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The enzymatic mechanisms of resistance to aminoglycoside antibiotics in methicillin-cephem-resistant Staphylococcus aureus].
    Matsuhashi Y; Yamamoto H
    Jpn J Antibiot; 1988 May; 41(5):523-9. PubMed ID: 3216474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activity and ototoxicity in guinea pigs, and nephrotoxicity in rats of arbekacin.
    Kurebe M; Yokota M; Niizato T; Kai F; Yoshida T; Okamoto R; Mitsuhashi S
    Arzneimittelforschung; 1986 Oct; 36(10):1511-7. PubMed ID: 3814212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amikacin: Uses, Resistance, and Prospects for Inhibition.
    Ramirez MS; Tolmasky ME
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29257114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibacterial activities of arbekacin, a new aminoglycoside antibiotic, against methicillin-cephem-resistant Staphylococcus aureus].
    Watanabe T; Goi H; Hara T; Sugano T; Tanaka Y; Kazuno Y; Matsuhashi Y; Yamamoto H; Yokota T
    Jpn J Antibiot; 1987 Feb; 40(2):349-56. PubMed ID: 3648153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aranorosin circumvents arbekacin-resistance in MRSA by inhibiting the bifunctional enzyme AAC(6')/APH(2″).
    Suga T; Ishii T; Iwatsuki M; Yamamoto T; Nonaka K; Masuma R; Matsui H; Hanaki H; Omura S; Shiomi K
    J Antibiot (Tokyo); 2012 Oct; 65(10):527-9. PubMed ID: 22760297
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.
    Zapor MJ; Barber M; Summers A; Miller GH; Feeney LA; Eberly LE; Wortmann G
    Antimicrob Agents Chemother; 2010 Jul; 54(7):3015-7. PubMed ID: 20404121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia.
    Sader HS; Rhomberg PR; Farrell DJ; Jones RN
    Antimicrob Agents Chemother; 2015; 59(6):3263-70. PubMed ID: 25801559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Susceptibility of methicillin-resistant Staphylococcus aureus to various antibiotics. Classification by aminoglycoside-modifying enzymes and antibiotics active against MRSA].
    Kondo S; Ikeda Y; Hattori S; Hamada M; Takeuchi T
    Jpn J Antibiot; 1991 Nov; 44(11):1211-5. PubMed ID: 1664469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a bifunctional aminoglycoside-modifying enzyme with novel substrate specificity and its gene from a clinical isolate of methicillin-resistant Staphylococcus aureus with high arbekacin resistance.
    Ishino K; Ishikawa J; Ikeda Y; Hotta K
    J Antibiot (Tokyo); 2004 Oct; 57(10):679-86. PubMed ID: 15638329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antibacterial activity of 1-N-[(S)-ω-amino-2-hydroxyalkyl] derivatives of dibekacin, 5-deoxydibekacin, 3'-deoxykanamycin A and gentamicin B.
    Umemura E; Sakamoto Y; Takahashi Y; Miyake T
    J Antibiot (Tokyo); 2015 Jun; 68(6):421-3. PubMed ID: 25712399
    [No Abstract]   [Full Text] [Related]  

  • 36. Basic and applied research on multiple aminoglycoside antibiotic resistance of actinomycetes: an old-timer's recollection.
    Hotta K
    J Ind Microbiol Biotechnol; 2021 Dec; 48(9-10):. PubMed ID: 34402899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vancomycin and arbekacin, drugs of treatment for MRSA infections].
    Kobayashi Y
    Nihon Rinsho; 1992 May; 50(5):1054-9. PubMed ID: 1507428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of multiple aminoglycoside resistance of kasugamycin-producing Streptomyces kasugaensis MB273: involvement of two types of acetyltransferases in resistance to astromicin group antibiotics.
    Hotta K; Ogata T; Ishikawa J; Okanishi M; Mizuno S; Morioka M; Naganawa H; Okami Y
    J Antibiot (Tokyo); 1996 Jul; 49(7):682-8. PubMed ID: 8784431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes.
    Barada K; Hanaki H; Ikeda S; Yamaguchi Y; Akama H; Nakae T; Inamatsu T; Sunakawa K
    J Infect Chemother; 2007 Apr; 13(2):74-8. PubMed ID: 17458673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of 5-deoxy-5-epifluoro derivatives of arbekacin, amikacin, and 1-N-[(S)-4-amino-2-hydroxybutanoyl]tobramycin (study on structure--toxicity relationships).
    Shitara T; Umemura E; Tsuchiya T; Matsuno T
    Carbohydr Res; 1995 Oct; 276(1):75-89. PubMed ID: 8536259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.